Rheumatology
Rheumatology
Advertisement
Mithu Maheswaranathan, MDRheumatology | October 4, 2024
A study sought to understand the use of herbal supplement treatment in adult patients with autoimmune skin diseases.
Read More
Mithu Maheswaranathan, MDRheumatology | August 19, 2024
A study examined the phenotypic differences in patients with IgG4-RD with and without hypocomplementemia.
Rebecca AraujoLupus | August 15, 2024
The US FDA approved the application for for equecabtagene autoleucel for the treatment of lupus.
Mithu Maheswaranathan, MDPsoriatic Arthritis | August 1, 2024
The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood.
Mithu Maheswaranathan, MDLupus | July 19, 2024
Dr. Mithu Maheswaranathan on a study that shows metformin is a promising complementary therapy for SLE.
Rebecca AraujoLupus | July 16, 2024
Patients with genetic risk factors with long-term exposure had a significantly higher risk of developing SLE.
Rebecca AraujoOsteoporosis | July 1, 2024
A study found an independent relationship between hypertension and osteoporosis.
Rebecca AraujoPsoriatic Arthritis | June 21, 2024
Treatment with ixekizumab led to rapid improvements in joint, skin, and nail symptoms for patients with psoriatic arthritis.
Mithu Maheswaranathan, MDLupus | June 4, 2024
A study assessed glucocorticoid regimens on renal response, infections, and mortality in patients with lupus nephritis.
Rebecca AraujoRheumatology | May 28, 2024
Systemic lupus erythematosus may be related to a greater risk of pregnancy complications.
Rebecca AraujoLupus | May 17, 2024
A study assessed factors associated with kidney involvement in patients with systemic lupus erythematosus.
Rebecca AraujoPsoriatic Arthritis | May 14, 2024
A study of real-world treatment and outcomes associated with ixekizumab found favorable efficacy in patients.
Rebecca AraujoRheumatology | May 3, 2024
The FDA has approved Cyltezo, for the treatment of chronic inflammatory diseases.
Mithu Maheswaranathan, MDRheumatology | April 29, 2024
There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology.
Rebecca AraujoPsoriatic Arthritis | April 19, 2024
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Rebecca AraujoPsoriatic Arthritis | April 17, 2024
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Mithu Maheswaranathan, MDRheumatology | April 12, 2024
A study analyzed the use of after-visit instructions at rheumatology clinics.
Rebecca AraujoPsoriatic Arthritis | April 2, 2024
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Rebecca AraujoRheumatology | March 25, 2024
Reproductive health outcomes appear to be greatly impacted by the presence of rheumatic diseases.
Rebecca AraujoOsteoarthritis | March 19, 2024
Between 1990 and 2019, the global incidence of early-onset osteoarthritis doubled.
Advertisement
Advertisement
Advertisement
Latest News

October 30, 2024